PAVAN, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 11.718
AS - Asia 6.579
EU - Europa 3.309
SA - Sud America 971
AF - Africa 138
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 22.729
Nazione #
US - Stati Uniti d'America 11.464
SG - Singapore 2.509
CN - Cina 1.636
BR - Brasile 751
VN - Vietnam 728
IT - Italia 610
UA - Ucraina 599
HK - Hong Kong 559
DE - Germania 522
GB - Regno Unito 358
TR - Turchia 346
FI - Finlandia 230
FR - Francia 215
PL - Polonia 197
JP - Giappone 187
SE - Svezia 166
RU - Federazione Russa 165
IN - India 150
MX - Messico 116
CA - Canada 113
AR - Argentina 85
ID - Indonesia 79
BD - Bangladesh 69
PK - Pakistan 52
ZA - Sudafrica 51
NL - Olanda 50
IQ - Iraq 44
ES - Italia 38
EC - Ecuador 35
CO - Colombia 32
LT - Lituania 27
PH - Filippine 27
UZ - Uzbekistan 23
MA - Marocco 22
AT - Austria 21
CL - Cile 19
MY - Malesia 19
VE - Venezuela 19
KE - Kenya 18
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
BE - Belgio 16
PY - Paraguay 16
CZ - Repubblica Ceca 15
TW - Taiwan 15
TN - Tunisia 13
IL - Israele 11
KR - Corea 11
IE - Irlanda 10
IR - Iran 10
EG - Egitto 9
NO - Norvegia 9
RS - Serbia 9
AU - Australia 8
DK - Danimarca 8
DZ - Algeria 8
JO - Giordania 8
TH - Thailandia 8
CH - Svizzera 7
BG - Bulgaria 6
KZ - Kazakistan 6
LB - Libano 6
NP - Nepal 6
OM - Oman 6
PE - Perù 6
PS - Palestinian Territory 6
RO - Romania 6
BO - Bolivia 5
JM - Giamaica 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
AL - Albania 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
HU - Ungheria 3
NG - Nigeria 3
PA - Panama 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CG - Congo 2
HN - Honduras 2
ME - Montenegro 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
Totale 22.708
Città #
Singapore 1.563
Ashburn 1.301
Fairfield 1.058
Woodbridge 1.040
San Jose 701
Houston 640
Jacksonville 634
Hong Kong 545
Santa Clara 525
Beijing 514
Chandler 509
Ann Arbor 447
Seattle 418
Wilmington 367
Cambridge 361
Ho Chi Minh City 231
Izmir 231
Ferrara 226
Warsaw 190
Nanjing 181
Los Angeles 171
Tokyo 171
New York 159
Hanoi 158
Princeton 147
The Dalles 143
Dallas 141
Boardman 131
Lauterbourg 122
Munich 102
San Diego 97
Milan 85
Council Bluffs 77
Addison 72
São Paulo 71
Helsinki 68
Mexico City 68
Shanghai 58
Orem 57
London 55
Jakarta 52
Hebei 51
Hefei 51
Brooklyn 50
Nanchang 50
Shenyang 49
Turku 44
Frankfurt am Main 41
Buffalo 38
Dong Ket 36
Rio de Janeiro 36
Chennai 34
Chicago 33
Montreal 33
Tianjin 32
Atlanta 31
Bremen 30
Changsha 30
Da Nang 30
Dearborn 29
Falls Church 28
Redwood City 28
Toronto 27
Chongqing 25
Johannesburg 25
Jiaxing 24
Bologna 23
Moscow 23
Mountain View 23
San Mateo 23
Denver 22
Stockholm 22
Tashkent 22
Haiphong 21
Amsterdam 20
Auburn Hills 20
San Francisco 20
Hải Dương 19
Kunming 19
Jinan 17
Norwalk 17
Phoenix 17
Rome 17
Belo Horizonte 16
Manchester 16
Poplar 16
Ankara 15
Boston 15
Mumbai 15
Nairobi 15
Nuremberg 15
Salt Lake City 15
Baghdad 14
Biên Hòa 14
Washington 14
Orange 13
Porto Alegre 13
Querétaro 13
Vancouver 13
Augusta 12
Totale 15.361
Nome #
cAMP efflux from human trophoblast cell lines: A role for multidrug resistance protein (MRP)1 transporter 292
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 280
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 278
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 273
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 256
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 251
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 246
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 246
Conjugation of aspirin with vitamin C: uptake and stability studies 239
17 beta-estradiol stimulates arachidonate release from human amnion-like WISH cells through a rapid mechanism involving a membrane receptor 237
Circadian clocks regulate adenylyl cyclase activity rhythms in human RPE cells 232
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 231
"Low" concentrations of sodium fluoride inhibit neurotransmitter release from the guinea-pig superior cervical ganglion. 230
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 221
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 220
Adenosine analogs inhibit acetylcholine release and cyclic AMP synthesis in the guinea-pig superior cervical ganglion 220
17β-estradiol modulates prostaglandin E2 release from human amnion-derived WISH cells 220
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity 217
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 214
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 212
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 211
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 206
Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice 203
Inhibition of amniotic interleukin-6 and prostaglandin E-2 release by ampicillin 203
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 202
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 201
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 200
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 199
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: Effect of steroids, flavonoids and NSAIDs 196
Prostaglandin E-2 inhibits proliferation and migration of HTR-8/SVneo cells, a human trophoblast-derived cell line 195
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 195
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 193
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 192
L’estradiolo stimola la vitalità di cellule endoteliali microvascolari cerebrali in vitro isolate da pazienti neurochirurgici 190
Beta-Adrenoreceptor Agonism Influences Retinal Responses to Hypoxia in a Model of Retinopathy of Prematurity 190
Biochemical and pharmacological characterization of adenosine A1 receptors in eel (Anguilla anguilla) brain 189
Formyl-methionyl-leucyl-phenylalanine induces prostaglandin E2 release from human amnion-derived WISH cells by phospholipase C-mediated [Ca2+]i rise 187
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 184
The role and modulation of the oxidative balance in pregnancy 184
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 184
Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications 183
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 179
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 179
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 178
Influence of oxytocin on prostaglandin E-2, intracellular calcium, and cyclic adenosine monophosphate in human amnion-derived (WISH) cells 178
Progress in drug delivery to the central nervous system by the prodrug approach 177
Cross-talk between nitridergic and prostaglandinergic pathways in amnion-like WISH cells 174
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 174
Adenosine enhances acetylcholine receptor channel openings and intracellular calcium 'spiking' in mouse skeletal myotubes. 171
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 170
β-methasone, progesterone and RU-486 (mifepristone) exert similar effects on connexin expression in trophoblast-derived HTR-8/SVneo cells. 168
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 167
Bile acids modulation of nanoparticle macrophage uptake 165
Cobalt chloride induced hypoxia and lipid peroxidation in HRPE cells 158
Processing of adenosine receptor agonists in rat and human whole blood 158
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 157
Use of Glucocorticoids in Pregnancy 156
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 156
Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide 156
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 155
Chlorogenic acid permeation across intestinal cell monolayers: influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 155
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission. 154
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 154
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 154
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 154
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 152
High glucose-induced barrier impairment of human retinal pigment epithelium is ameliorated by treatment with Goji berry extracts through modulation of cAMP levels. 152
Characterization and Hydrolysis Studies of a Prodrug Obtained as Ester Conjugate of Geraniol and Ferulic Acid by Enzymatic Way 151
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 151
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 150
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 149
Coniugati dell’acido ascorbico ad attività neurotropica. 149
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 146
Biological activity of somatostatin receptors in GC rat tumour somatotrophs: Evidence with sst1-sst5 receptor-selective nonpeptidyl agonists 146
Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers 146
Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release 145
The cyclooxygenase-2/prostaglandin E2 pathway is involved in the somatostatin-induced decrease of epileptiform bursting in the mouse hippocampus 142
Quercetin and quercetin-3-O-glucoside interact with different components of the cAMP signaling cascade in human retinal pigment epithelial cells 139
Interactions between the nitric oxide and prostaglandin E2 biosynthetic pathways in human amnion-like WISH cells. 139
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 139
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: A thermodynamic analysis 138
METODO PER MODULARE L'ASSORBIMENTO FAGOCITARIO DI UN PRINCIPIO ATTIVO O UN SUO PRECURSORE DA PARTE DI MACROFAGI 138
Effect of different classes of antibiotics on amniotic prostaglandin E release 137
Caratterizzazione di potenziali profarmaci di derivati adenosinici ad attività antiischemica. 135
Stereochimica e tossicità 134
WISH cells as a model for the "in vitro" study of amnion pathophysiology. 134
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 134
Evaluation of the in vitro biocompatibility of PEDOT: Nafion coatings 134
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 134
Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus 133
Release modulation of hydrophilic drugs from polymeric nanoparticles produced by in-oil nanoprecipitation process 132
Evidence for a circadian clock in HRPE cells controlling adenylyl cyclase activity rhythms 131
Ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids: design, synthesis and activity 131
Role of oxidative stress in chemical hypoxia induced apoptosis 130
Inhibition of amniotic prostaglandin E release by ampicillin 129
Estrogens metabolites in the release of inflammatory mediators from human amnion-derived cells 128
Odorants could elicit repair processes in melanized neuronal and skin cells 128
Conjugation of Dopamine and an A2A Adenosine Receptor Antagonist: a possible approach for the treatment of Parkinson’s Disease. 126
Circadian and dopaminergic influence on chlorogenic acid intestinal permeability 125
Thermodynamic in vitro studies as a method to investigate the in vivo behaviour of adenosine A1 receptor ligands. 123
Totale 17.679
Categoria #
all - tutte 98.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.036
Totale 99.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 0 0 0 0 0 233 123
2021/20221.315 37 174 103 50 44 47 57 65 53 99 111 475
2022/20231.223 142 60 45 148 223 185 43 95 151 8 78 45
2023/2024720 68 93 36 21 57 90 31 36 17 14 30 227
2024/20253.237 69 70 270 155 425 300 90 197 477 377 459 348
2025/20268.693 860 386 823 1.260 1.246 606 1.029 548 874 1.044 17 0
Totale 22.968